Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia

被引:0
作者
Paulo R. Batista
Alan Wilter
Elza H. A. B. Durham
Pedro G. Pascutti
机构
[1] Universidade Federal do Rio de Janeiro,Laboratório de Modelagem e Dinâmica Molecular, Instituto de Biofisica Carlos Chagas Filho
[2] Laboratório Nacional de Computação Cientifica,Instituto de Matemática e Estatistica
[3] Instituoo Ludwig de Pesquisa sobre o Câncer,undefined
[4] Universidade São Paulo,undefined
来源
Cell Biochemistry and Biophysics | 2006年 / 44卷
关键词
Molecular Dynamics; Gromacs; HIV-1 protease; ritonavir; subtypes; non-B; modelling; free energy; LIE;
D O I
暂无
中图分类号
学科分类号
摘要
Africa accounts for the majority of HIV-1 infections worldwide caused mainly by the A and C viral subtypes rather than B subtype, which prevails in the United States and Western Europe. In Brazil, B subtype is the major subtype, but F, C, and A also circulate. These non-B subtypes present polymorphisms, and some of them occur at sites that have been associated with drug resistance, including the HIV-1 protease (PR), one important drug target. Here, we report a Molecular Dynamics study of the B and non-B PR complexed with the inhibitor ritonavir to delineate the behavior of each subtype. We compare root mean squared deviation, binding free energy by linear interaction energy approach, hydrogen bonds, and intermolecular contact surface area between inhibitor and PR. From our results, we can provide a basis to understand the molecular mechanism of drug resistance in non-B subtypes. In this sense, we found a decrease of approx 4 kcal/mol in ΔG of binding between B and non-B subtypes. This corresponds to the loss of one hydrogen bond, which is in agreement with our H-bond analysis. Previous experimental affinity studies reported analogous results with inhibition constant values for non-B PR.
引用
收藏
页码:395 / 404
页数:9
相关论文
共 135 条
  • [1] Hu W. S.(1990)Retroviral recombination and reverse transcription Science 250 1227-1233
  • [2] Temin H. M.(1988)Fidelity of HIV-1 reverse transcriptase Science 242 1168-1171
  • [3] Preston B. D.(1995)Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 123-126
  • [4] Poiesz B. J.(1998)Identification of a new human immunodeficiency virus type 1 distinct from group M and group O Nat. Med. 4 1032-1037
  • [5] Loeb L. A.(2003)Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution AIDS Rev. 5 25-35
  • [6] Ho D. D.(2004)HIV-1 subtype distribution and the problem of drug resistance AIDS 18 S63-S68
  • [7] Neumann A. U.(2002)Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000 J. Acquir. Immun. Defic. Syndr. 29 184-190
  • [8] Perelson A. S.(2004)Primary HIV-1 drug resistance in Brazil AIDS 18 S9-S13
  • [9] Chen W.(2000)How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease J. Mol. Biol. 301 1207-1220
  • [10] Leonard J. M.(2002)Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations Protein Sci. 11 221-232